TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Recipharm AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
473,894
|
397,890
|
180,237 |
Financial expenses |
4,386,032
|
2,290,937
|
1,190,868 |
Earnings before taxes |
-5,917,519
|
-14,091
|
57,304 |
EBITDA |
-205,865
|
-117,878
|
-180,787 |
Total assets |
15,413,024
|
19,719,153
|
12,628,971 |
Current assets |
8,743,193
|
2,656,132
|
1,815,273 |
Current liabilities |
2,954,997
|
1,412,956
|
1,209,238 |
Equity capital |
6,154,698
|
12,017,706
|
5,138,472 |
- share capital |
33,959
|
33,785
|
36,762 |
Employees (average) |
60
|
67
|
64 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.9%
|
60.9%
|
40.7% |
Turnover per employee |
7,898
|
5,939
|
2,816 |
Profit as a percentage of turnover |
-1248.7%
|
-3.5%
|
31.8% |
Return on assets (ROA) |
-9.9%
|
11.5%
|
9.9% |
Current ratio |
295.9%
|
188.0%
|
150.1% |
Return on equity (ROE) |
-96.1%
|
-0.1%
|
1.1% |
Change turnover |
73,955
|
232,252
|
-7,868,090 |
Change turnover % |
18%
|
140% | |
Chg. No. of employees |
-7
|
3
|
-7,793 |
Chg. No. of employees % |
-10%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.